Latest Market News

MRG Metals has achieved a major milestone with the official approval and signing of the Corridor Central Heavy Mineral Sands mining licence in Mozambique, unlocking development potential for its world-class Koko Massava deposit.

Arrow Minerals is fast-tracking a Scoping Study for a Direct Shipping Ore operation at its Niagara Bauxite Project in Guinea, leveraging strong drilling results and strategic infrastructure access to capitalise on record bauxite prices.

Centrex Limited has initiated a $10.4 million entitlement offer to fund essential plant upgrades and strengthen working capital, following a strategic logistics debt restructuring. The raise is pivotal for advancing the Ardmore phosphate project and maintaining financial viability.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

EQ Resources announces a strategic leadership reshuffle, transitioning CEO Kevin MacNeill to CTO to sharpen operational focus and support ambitious growth plans across Australia and Spain.

Peninsula Energy has resumed uranium production at its Lance Project in Wyoming, capturing 1,100 pounds of uranium in late December 2024, while securing key regulatory approvals to expand mining operations.

Latrobe Magnesium Limited has responded to an ASX price query, denying any undisclosed information that could explain the recent sharp drop in its share price and surge in trading volume.

Amcor plc and Berry Global Group, Inc. have entered into a definitive merger agreement for an all-stock transaction valued at approximately $9.9 billion. The combined entity aims to leverage significant synergies and enhanced market reach, pending shareholder and regulatory approvals.

Brazilian Critical Minerals has released an updated Mineral Resource Estimate for its Ema rare earth project in Brazil, defining a robust 350Mt starter zone at 778ppm TREO. This milestone underpins the imminent Scoping Study and signals promising economic potential for the project.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.

The Australian Takeovers Panel has declared unacceptable circumstances in Alara Resources Limited's recent rights issue, citing inadequate disclosure and potential control issues involving Al Tasnim Infrastructure LLC. The company faces a costs order and must reassess its fundraising approach.

Foresta Group Holdings secures a significant regulatory boost as its Kawerau renewable energy project is included in New Zealand’s Fast-Track Approvals Act 2024, expediting the path to construction and operation.